Clinical and molecular features of DYT1 primary dystonia in a Peruvian population
Objective: To associate clinical data of dystonia patients with the TOR1-A gene mutation in Peru. Background: DYT1 dystonia is a severe generalized form of early-onset…Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment
Objective: Case reports. Background: Although botulinum toxin is routinely used as first-line treatment for focal dystonias, little is known about its usefulness in the treatment…Motor variability and learning indices in DYT1 dystonia
Objective: To examine motor variability in DYT1 dystonia and its interaction with subtypes of motor learning. Background: In healthy subjects it is now known that…Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report
Objective: To report two atypical associations of pRBD and DO we came across with a case of primary cervical dystonia. Background: RBD (REM sleep Behaviour…Axial prominent, delayed onset dystonia in cerebral palsy: Highlights on a distinct phenotype with favorable outcome following deep brain stimulation
Objective: To report on a subgroup of DCP patients with delayed onset of dystonia who received DBS therapy. Background: Dyskinetic cerebral palsy (DCP) is the…Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible
Objective: To describe the clinical and imaging features of patients who developed dystonia-parkinsonism syndrome due to cyclosporine A(CsA). Background: CsA is an immunosuppressant widely used…The clinical benefit of pallidal stimulation in dystonia is related to the electrode position in the medio-lateral direction
Objective: To detect the relationship between the long-term clinical outcome of deep brain stimulation (DBS) in patients with dystonia and the electrode position in the…Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To compare the effects of botulinum toxin A (BtA) versus anticholinergics in adults with cervical dystonia (CD). Background: This is an update of a…Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to placebo in adults with hemifacial spasm (HFS). Background: This is an update…Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to type B (BtB) in adults with cervical dystonia (CD). Background: This is…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.